期刊文献+

人脐带间充质干细胞培养上清液与环丙沙星体外联合应用对金黄色葡萄球菌的作用 被引量:2

Effects of combined application of culture supernatant of human umbilical cord mesenchymal stem cells and ciprofloxacin on Staphylococcus aureus in vitro
原文传递
导出
摘要 目的探讨联合应用人脐带间充质干细胞(hUCMSC)培养上清液与环丙沙星对金黄色葡萄球菌的作用。方法取足月剖宫产健康胎儿的脐带组织,分离、培养、鉴定hUCMSC后选取第3代细胞进行实验;取笔者单位烧伤患者创面分离培养的金黄色葡萄球菌菌株用于以下实验。按随机数字表法(下同)将细胞分为0、10、100、1000ng/mLLPS组,添加相应质量浓度LPS处理12h后,换为间充质干细胞(MSC)培养液培养,培养6、12、24h,每组收集6孔细胞培养上清液,ELISA法测定LL-37含量。将90个血琼脂平板培养基分为环丙沙星对照组、环丙沙星+上清液组、环丙沙星+上清液+LL-37抗体组,每组30个。环丙沙星对照组培养基涂布1.5×10^8CFU/mL生理盐水配制的菌液;环丙沙星+上清液组培养基涂布1.5×10^8CFU/mL由生理盐水和2倍生理盐水体积的hUCMSC培养上清液(用MSC培养液培养,下同)配制的菌液;环丙沙星+上清液+LL-37抗体组培养基涂布1.5×10^8CFU/mL由生理盐水和2倍生理盐水体积的hUCMSC培养上清液配制的菌液,菌液中加入2μg/mLLL-37抗体2.6μL。培养12、24、48h,每组取10个血琼脂平板培养基,观察血琼脂平板培养基上金黄色葡萄球菌菌落分布情况,测量环丙沙星抑菌环直径,读取环丙沙星对金黄色葡萄球菌的MIC。计算环丙沙星+上清液组和环丙沙星+上清液+LL-37抗体组培养12、24、48h时环丙沙星的部分抑菌浓度(FIC)指数并评定协同效果。对数据行析因设计方差分析、单因素方差分析、LSD-t检验、Kruskal—Wallis检验、Mann-WhitneyU检验。结果(1)培养各时相点,10、100、1000ng/mLLPS组细胞培养上清液中LL-37含量均较0ng/mLLPS组高(t值为11.22~33.36,P值均小于0.01),100、1000ng/mLLPS组细胞培养上清液中LL-37含量均较10ng/mLLPS组高(t值为2.24~18.73,P〈0.05或P〈0.01),1000ng/mLLPS组细胞培养上清液中LL-37含量均较100ng/mLLPS组高(t值为12.46~14.70,P值均小于0.01)。(2)培养12、24、48h,环丙沙星对照组、环丙沙星+上清液组、环丙沙星+上清液+LL-37抗体组血琼脂平板培养基中细菌菌落随时间延长逐渐融合。环丙沙星对照组培养12、24、48h环丙沙星抑菌环直径变化不大,分别为26、24、23mm。环丙沙星+上清液组、环丙沙星+上清液+LL-37抗体组培养12、24、48h环丙沙星抑菌环直径分别为82、71、68mm和74、59、56mm,明显大于环丙沙星对照组。(3)培养各时相点,环丙沙星对照组环丙沙星对金黄色葡萄球菌的MIC明显大于环丙沙星+上清液组和环丙沙星+上清液+LL-37抗体组(z值为6.22~6.71,P值均小于0.01);环丙沙星+上清液十LL-37抗体组环丙沙星对金黄色葡萄球菌的MIC均明显大于环丙沙星+上清液组(z值均为6.72,P值均小于0.01)。(4)环丙沙星+上清液组、环丙沙星+上清液+LL-37抗体组培养12、24、48h时环丙沙星的FIC指数分别为0.011、0.032、0.032,0.122、0.350、0.350,即hUCMSC培养上清液对环丙沙星产生了协同抗菌作用。结论hUCMSC能够分泌LL-37且分泌水平随着LPS浓度的增加而提高。hUCMSC培养上清液联合环丙沙星抗金黄色葡萄球菌,可以有效降低环丙沙星用量,中和LL-37后,hUCMSC培养上清液的协同抗菌作用降低。 Objective To explore the effects of combined application of culture supernatant of hu- man umbilical cord mesenchymal stem ceils (hUCMSCs) and ciprofloxacin on Staphylococcus aureus (SA) in vitro. Methods hUCMSCs were isolated from umbilical cord tissue of full-term healthy fetus after cesarean section and cultured. Ceils in the third passage were used in the experiments after identification. SA strains isolated from wounds of burn patients in our burn wards were used in the experiments. Cells were divided into 0, 10, 100, and 1 000 ng/mL lipopolysaccharide (LPS) groups according to the random number table (the same dividing method below). Cells were cultured with culture medium of mesenchymal stern cells (MSCs) after being treated with medium containing the corresponding mass concentrations of LPS for 12 h. At post culture hour (PCH) 6, 12, and 24, 6 wells of culture supernatant of ceils in each group were obtained to measure the content of LL-37 with enzyme-linked immunosorbent assay. Ninety blood agar plates were divided into ciprofloxacin control group (CC) , ciprofloxacin + supernatant group (CS) , and ciprofloxacin + supernatant + LL-37 antibody group (CSL) , with 30 blood agar plates in each group. Blood agar plates in group CC were coated with 1.5 ×10^8 colony forming unit (CFU)/mL bacteria solution prepared with normal saline. Blood agar plates in group CS were coated with 1.5×10^8 CFU/mL bacteria solution prepared with normal saline and culture supernatant of hUCMSCs ( cultured by culture medium of MSCs, the same below) in double volume of normal saline. Blood agar plates in group CSL were coated with 1.5×10^8 CFU/mL bacteria solution prepared with normal saline, culture supernatant of hUCMSCs in double volume of normal saline, and 2.6 μL LL-37 antibody in the concentration of 2 μg/mL. At PCH 12, 24, and 48, 10 blood agar plates of each group were harvested to observe the distribution of SA colony on blood agar plate and to measure the diameter of bacterial inhibition ring of ciprofloxacin. The minimum inhibitory concentration (MIC) of ciprofloxacin against SA of each group was recorded. Fractional inhibitory concentration (FIC) indexes of ciprofloxacin in groups CS and CSL at PCH 12, 24, and 48 were calculated, and the effect of syner- gy was evaluated. Data were processed with analysis of variance of factorial design, one-way analysis of vari- ance, LSD- t test, Kruskal-Wallis test, and Mann-Whitney U test. Results (1) At each PCH, the con- tent of LL-37 in culture supernatant of cells in 10, 100, and 1 000 ng/mL LPS groups was higher than that in 0 ng/mL LPS group (with t values from 11.22 to 33.36, P values below 0.01) ; the content of LL-37 in cuhure supernatant of cells in 100 and 1 000 ng/mL LPS groups was higher than that in 10 ng/mL LPS group (withtvalues from 2.24 to 18.73, P 〈0.05 orP 〈0.01); the content of LL-37 in culture supernatant of cells in 1 000 ng/mL LPS group was higher than that in 100 ng/mL LPS group (with t values from 12.46 to 14.70, P values below 0.01 ). (2) At PCH 12, 24, and 48, the bacterial colonies in groups CC, CS, and CSL began to integrate over time. At PCH 12, 24, and 48, the diameters of bacterial inhibition ring of cip- rofloxacin in group CC were 26, 24, and 23 ram, respectively, with no obvious change. At PCH 12, 24, and 48, the diameters of bacterial inhibition ring of eiprofloxacin in groups CS and CSL were 82, 71, 68 ram, and 74, 59, 56 mm, respectively, significantly longer than those of group CC. (3) At each PCH, the MIC of eiprofloxacin against SA was significantly higher in group CC than in groups CS and CSL ( with Z values from 6.22 to 6.71, P values below 0. 01 ) ; the MIC of ciprofloxacin against SA was significantly high- er in group CSL than in group CS (with Z values all equal to 6.72, P values below 0.01 ). (4) FIC indexes of ciprofloxacin in groups CS and CSL at PCH 12, 24, and 48 were 0.011, 0.032, 0.032, and 0. 122, 0. 350, 0. 350, respectively. The results indicated that culture supernatant of hUCMSCs had synergistically antibacterial effect on ciprofloxacin. Conclusions hUCMSCs ean secrete LL-37, and the seeretion level is increased with increase of LPS concentration. Combination of culture supernatant of hUCMSCs and ciproflox- acin can decrease the dosage of ciprofloxacin in resisting SA. Once LL-37 is neutralized, the synergistically antibacterial effect of culture supernatant of hUCMSCs is decreased.
作者 周彪 屠华雷 巴特 王凌峰 王淑杰 聂顺义 Zhou Biao Tu Hualei Ba Te Wang Ling-feng Wang Shujie Nie Shunyi(Department of Burns, the Third Affiliated Hospital of Inner Mongolia Medical University, Burn Institute of lnner Mongolia, Baotou 014010, China)
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2017年第6期355-360,共6页 Chinese Journal of Burns
基金 内蒙古自治区自然科学基金(2015MS0815)
关键词 间质干细胞 葡萄球菌 金黄色 抗菌肽类 环丙沙星 Mesenchymal stem cells Staphylococcus aureus Dcrmcidins Ciprofloxaein
  • 相关文献

参考文献5

二级参考文献88

  • 1郑晓珂,史社坡,毕跃峰,冯卫生,王继峰,牛建昭.卷柏中一个新木脂素苷的分离与鉴定[J].药学学报,2004,39(9):719-721. 被引量:28
  • 2郑晓珂,吕鹏飞,王玲巧,冯卫生,王继峰,牛建昭.卷柏等5种中药植物雌激素活性筛选的实验研究[J].中国中药杂志,2006,31(15):1254-1257. 被引量:20
  • 3Yan Zhi Wang Hui Chen Xiao Ke Zheng Wei Sheng Feng.A new sesquilignan from Selaginella sinensis (Desv.) Spring[J].Chinese Chemical Letters,2007,18(10):1224-1226. 被引量:15
  • 4Semont A, Mouiseddine M, Francois A, et al. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ. 2010;17(6):952-961.
  • 5Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709-716.
  • 6Marx J. Cancer research. Mutant stem cells may seed cancer. Science. 2003;301 (5638): 1308-1310.
  • 7Menasch P. Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives. Thromb Haemost. 2005;94(4):697-701.
  • 8Sell S. On the stem celt origin of cancer. Am J Pathol. 2010; 176(6):2584-2494.
  • 9Khubutiya MS, Vagabov AV, Temnov hA, et al. Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy. 2014;16(5): 579-585.
  • 10van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47(5): 1634-1643.

共引文献46

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部